Market report / Perrigo weighs on higher market
Shares of local generic drugmaker fall 4.4% after $8.6 billion buy of Irish biotech firm Elan
Perrigo plunged in heavy trading on the Tel Aviv Stock Exchange after its $8.6 billion purchase of the Irish drug maker Elan on Monday, weighing down the benchmark TA-25 index in a generally up market. Lower share prices in the Far East and on Wall Street buttressed the trend.
Like us on Facebook and get articles directly in your news feed